Eterus Capital has acquired an additional stake in GroupSolver
Eterus Capital, a.s. has acquired an additional stake in GroupSolver Inc.
Founded in 2008, Eterus Capital is an investor targeting small and medium-sized companies with growth potential, which have successfully proved their business concept. The fund only invests in minority positions while management control always remains in the hands of the original shareholders
GroupSolver is a market research technology company based in San Diego, California, with operations in Utah in the US, and Slovakia. It has built an intelligent market research platform “online survey with a brain” that helps businesses answer their burning why, how and what questions faster and with more confidence. By combining machine learning and crowd intelligence, the GroupSolver® technology helps decision-makers and researchers find insights that traditionally remain hidden from online surveys or focus groups.
Oaklins’ team in Slovakia acted as the exclusive sell-side advisor in this transaction, which was a follow-up from a previous investment in June 2020.
Talk to the deal team
Related deals
Lumiforte partners with Kartesia to propel global growth and innovation
Lumiforte, a global leader in innovative smart coatings for greenhouse horticulture, sports line-marking and other functional coatings for agriculture and industry, is excited to announce an investment from Kartesia, a European specialist in capital solutions for small and medium-sized companies. Horticoop, a longstanding shareholder of Lumiforte and a key player in the horticultural industry through its investment cooperative, continues to remain a shareholder.
Learn moreYxion has been acquired by Normec
Normec has acquired Dutch consultancy Yxion from Antea. Through this acquisition, Normec continues its acquisition strategy in Europe, while also looking for expansion opportunities in the United States.
Learn moreAMC Media Group has been acquired by Formedics
AMC Media Group, a healthcare professional (HCP) community platform that enables medical associations and key opinion leaders (KOLs) to drive engagement and monetization through their specialty digital properties, has been acquired by Formedics, an HCP community and engagement platform that is home to Physician’s Weekly and OncWeekly.
Learn more